ArticlePharmaceuticals (Basel, Switzerland)2022

Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response.

Chen Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.